[mailpoet_sector_follow]

US Broker Ratings

PACS Group, Inc. (PACS) Investor Outlook: Strong Buy Ratings Signal Potential 22% Upside

PACS Group, Inc. (PACS), a growing player in the healthcare sector, is making waves with its impressive market presence and financial performance. Headquartered in Salt Lake..

Addus HomeCare Corporation (ADUS) Stock Analysis: A 12.86% Upside Potential in the Healthcare Sector

Investors seeking opportunities in the healthcare sector may find Addus HomeCare Corporation (NASDAQ: ADUS) an intriguing prospect. With its unique positioning in the medical care facilities..

PGIM Securitized Income ETF (PINC) Stock Report: Stability in Securitized Credit Investments

For investors seeking stability in the often volatile world of investments, the PGIM Securitized Income ETF (NYSEARCA: PINC) offers a unique proposition. With a substantial market..

MannKind Corporation (MNKD) Stock Analysis: A 102.77% Potential Upside in the Biotech Arena

MannKind Corporation (MNKD), a pivotal player in the biotechnology sector, is catching the attention of investors with a remarkable potential upside of 102.77%. Specializing in innovative..

Clover Health Investments, Corp (CLOV)

⚠️ No article content returned.

..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring the 9.23% Potential Upside in the Booming Medical Devices Sector

For investors seeking exposure to the burgeoning healthcare sector, particularly within the medical devices industry, UFP Technologies, Inc. (NASDAQ: UFPT) presents an intriguing opportunity. With a..

Organon & Co. (OGN) Stock Analysis: Navigating the Healthcare Sector with Strategic Insights

Investors looking to navigate the complex landscape of healthcare investments might find Organon & Co. (NYSE: OGN) an intriguing prospect. With a market capitalization of $3.58..

Vera Therapeutics (VERA) Stock Analysis: A Biotech with Potential 157.85% Upside

Vera Therapeutics, Inc. (NASDAQ: VERA), a clinical-stage biotechnology company, stands at a pivotal point in its growth trajectory, with analysts projecting a significant potential upside of..

Liquidia Corporation (LQDA) Stock Analysis: Unpacking Robust Revenue Growth and Strategic Positioning

Liquidia Corporation (NASDAQ: LQDA), a prominent player in the healthcare sector, is capturing investor attention with its remarkable revenue growth and strategic advancements in treating rare..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a Potential 71% Upside in the Healthcare Sector

HUTCHMED (China) Limited (HCM), a key player in the healthcare sector, is drawing investor attention with its specialization in developing targeted therapeutics and immunotherapies to combat..

Mesoblast Limited (MESO) Stock Analysis: Unpacking the 109% Upside Potential and Latest Developments

Mesoblast Limited (MESO), a prominent player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 109.83%. With a market capitalization of..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Potential 91% Upside Awaits Investors

Beam Therapeutics Inc. (NASDAQ: BEAM), a prominent player in the biotechnology sector, captivates investor interest with its innovative approach to precision genetic medicines. Based in Cambridge,..

LivaNova PLC (LIVN) Stock Analysis: Healthcare Innovator with 16.89% Upside Potential

LivaNova PLC (NASDAQ: LIVN), a leading player in the medical devices sector, offers a compelling investment opportunity within the healthcare industry. Headquartered in the United Kingdom,..

Certara, Inc. (CERT) Stock Analysis: Navigating Growth in Health Information Services

Certara, Inc. (CERT), a prominent player in the health information services sector, offers investors a unique proposition with its technology-driven services and software products for biosimulation..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring a 13.67% Potential Upside in the Medical Devices Sector

AtriCure, Inc. (NASDAQ: ATRC) is positioning itself as a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market..

Structure Therapeutics Inc. (GPCR): Investor Outlook with Nearly 95% Potential Upside

Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising pipeline and substantial potential upside. Operating at the..

Evotec SE (EVO) Stock Analysis: Exploring an 84% Potential Upside for Strategic Investors

In the dynamic and highly competitive healthcare sector, Evotec SE (EVO) stands out as a significant player in the drug manufacturing industry, focusing on specialty and..

CONMED Corporation (CNMD)

⚠️ No article content returned.

..

DENTSPLY SIRONA (XRAY): Navigating Challenges with a 17.66% Potential Upside

For investors keeping an eye on the healthcare sector, DENTSPLY SIRONA Inc. (NASDAQ: XRAY) presents an intriguing proposition. This leading manufacturer in the medical instruments and..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Exploring a 63.62% Upside with Cutting-Edge Gene Editing Technologies

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of the biotechnology sector with its revolutionary gene-editing technologies. Headquartered in Zug, Switzerland, this pioneering company leverages..

Search

Funds

UK Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds